WILMINGTON, N.C.--(BUSINESS WIRE)--Pharmaceutical Product Development, LLC (PPD), a leading global contract research organization, announced today it has been named to Training magazine’s 2019 Training Top 125 list recognizing excellence in employee learning and development.
This marks the eighth consecutive year PPD has been named to the magazine’s list of top 125 businesses. The Training Top 125 is determined by evaluating companies that demonstrate measurable results in achieving business goals advanced by effective employee learning and development initiatives.
Training magazine also honored Amy Chapman, a principal learning specialist with PPD, as a Top 5 Emerging Training Leader. The award recognizes training professionals with two to 10 years of industry experience who have demonstrated stellar leadership skills, business savvy and training expertise.
“Employee engagement and growth are critical to PPD’s culture of high performance on behalf of our pharmaceutical and biotechnology clients,” said Jay Dixon, senior vice president of quality and enterprise learning at PPD. “Providing best-in-class learning and development programs ensures that our employees are well-equipped with the necessary skills to perform at the highest level and help ensure client success.”
PPD and Chapman were recognized during the annual Training 2019 Conference & Expo at Disney’s Coronado Springs Resort in Orlando, Florida.
“Being named to the Training Top 125 list for eight consecutive years exemplifies how PPD's learning and education mission provides exceptional training for employees that drive the company’s efforts to improve health,” said Lorri Freifeld, Training magazine’s editor-in-chief. “PPD does this by fostering a best-in-class learning culture with programs that proactively, measurably and efficiently improve employee growth, readiness and performance.”
About PPD
PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 48 countries and more than 21,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help clients and partners bend the cost and time curve of drug development and optimize value in delivering life-changing therapies to improve health. For more information, visit www.ppdi.com.
